Jisu Li Selected Research

Infections

1/2021	Naturally occurring 5' preS1 deletions markedly enhance replication and infectivity of HBV genotype B and genotype C.
1/2020	Expression Level of Small Envelope Protein in Addition to Sequence Divergence inside Its Major Hydrophilic Region Contributes to More Efficient Surface Antigen Secretion by Hepatitis B Virus Subgenotype D2 than Subgenotype A2.
1/2018	N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.
1/2016	Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
1/2016	A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
9/2015	From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
2/2015	Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
11/2013	Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID).
3/2013	Hepatitis B virus genetic variants: biological properties and clinical implications.
10/2011	Hepatitis B virus genotype C isolates with wild-type core promoter sequence replicate less efficiently than genotype B isolates but possess higher virion secretion capacity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jisu Li Research Topics

Disease

17	Infections 01/2021 - 06/2003
10	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2005
4	Hepatitis B 01/2018 - 11/2013
3	Persistent Infection 01/2021 - 09/2007
1	Neoplasms (Cancer) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Virus Diseases (Viral Diseases) 11/2013
1	Reinfection 02/2013
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2011
1	Fatty Liver 11/2008
1	Chronic Hepatitis C 09/2008

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2005
10	Hepatitis B e AntigensIBA 01/2021 - 06/2003
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2016
3	sodium-bile acid cotransporterIBA 01/2018 - 02/2015
2	Circular DNAIBA 01/2021 - 05/2010
2	Monoclonal AntibodiesIBA 01/2016 - 01/2016
2	VaccinesIBA 01/2016 - 02/2013
2	Complementary DNA (cDNA)IBA 09/2015 - 11/2008
2	Peptide Hydrolases (Proteases)FDA Link 11/2010 - 05/2010
1	Peptides (Polypeptides)IBA 01/2021
1	Viral AntigensIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 10/2016
1	hepatitis B hyperimmune globulinIBA 01/2016
1	Adenosine Triphosphatases (ATPase)IBA 01/2016
1	AntigensIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2016
1	CD2665IBA 02/2015
1	NucleosidesIBA 02/2015
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2015
1	Antiviral Agents (Antivirals)IBA 11/2013
1	ChemokinesIBA 11/2013
1	CytokinesIBA 11/2013
1	Interleukin-1 (Interleukin 1)IBA 11/2013
1	Cytidine DeaminaseIBA 11/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013
1	Viral DNAIBA 10/2011
1	FurinIBA 05/2010
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 05/2010
1	LipidsIBA 11/2008
1	Apolipoproteins C (ApoC)IBA 11/2008
1	Ku AutoantigenIBA 11/2008
1	PPAR gammaIBA 11/2008
1	ApolipoproteinsIBA 11/2008
1	Immunoglobulin FragmentsIBA 09/2008
1	Antisense RNA (Anti-Sense RNA)IBA 02/2004
1	Glycine Dehydrogenase (Decarboxylating)IBA 02/2004
1	Carrier Proteins (Binding Protein)IBA 02/2004

Therapy/Procedure

2	Therapeutics 01/2016 - 12/2010